Quia Pharma AB (publ) (QUIA.ST)
Quia Pharma AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Uppsala, SE. The stock last traded at $0.00, down 16.67% on the session, giving a market capitalisation of $1.3M. Its beta of 0.56 implies it has historically moved less than the broad market.
Quia Pharma AB specializes in the research, development, and commercialization of advanced drug delivery systems. Its core product, Uni-Qleaver®, utilizes a pioneering releasable pegylation technology. This innovative approach effectively mitigates common drawbacks and allows for the precise modulation of a drug's half-life. The company, established by Marek Kwiatkowski, is headquartered in Uppsala, Sweden.
Quia Pharma AB (publ) is most often compared with the following Healthcare names: